RE104 Clinical Lactation Study

Summary

The purpose of this study is to obtain data necessary to characterize the elimination of RE104 and metabolites from breastmilk of health lactating volunteers to support a regulatory assessment of when mothers can safely return to breastfeeding following a single-dose of RE104 for Injection.

Timeline

Start

2024-11-13

Primary completion

2025-05-28

Completion

2025-06-04

Drugs

Indications